Copyright
©2014 Baishideng Publishing Group Co.
World J Cardiol. Apr 26, 2014; 6(4): 148-153
Published online Apr 26, 2014. doi: 10.4330/wjc.v6.i4.148
Published online Apr 26, 2014. doi: 10.4330/wjc.v6.i4.148
Figure 1 Landmark analyses of PRODIGY Trial[13].
Cumulative rates of composite of death, myocardial infarction or cerebrovascular accident in all recruited patients (A) or in patients randomly allocated to the drug-eluting stent groups (B) using the 6 mo landmark analysis.
- Citation: Rha SW. Duration of dual antiplatelet treatment in the era of next generation drug-eluting stents. World J Cardiol 2014; 6(4): 148-153
- URL: https://www.wjgnet.com/1949-8462/full/v6/i4/148.htm
- DOI: https://dx.doi.org/10.4330/wjc.v6.i4.148